Archives
Gabapentin and pregabalin are anticonvulsants utilized in a wide array of conditions. These drugs share a similar chemical structure and share many of the same uses, so let’s take a look at gabapentin versus pregabalin? Mechanism of action: The precise mechanism of action of these drugs is not well known, but may rely on high-affinity […]
Read More
Last week, the FDA approved finerenone (Kerendia) to treat patients with chronic kidney disease (CKD) associated with type 2 diabetes. Finerenone is a nonsteroidal mineralocorticoid receptor antagonist (MRA). The approval of finerenone was due to the results of the recently completed FIDELIO-DKD trial, which demonstrated the protective effects of finerenone. How does it exhibit these […]
Read More
Ivermectin and hydroxychloroquine have been purported as potential COVID treatments. We break down where these drugs stand in regards to those claims. The NIH COVID-19 Treatment Guidelines Panel have recommended against any use of chloroquine or hydroxychloroquine (HCQ) for the treatment of COVID-19, including concomitantly with azithromycin. At this point in the pandemic, there has […]
Read More
Chemotherapeutic agents are used to control cancer cell proliferation, but they often come with toxicities to the host as well. It is important to monitor patients closely for the development of toxicities during therapy. Some of the potential toxicities of common chemotherapeutics are outlined below in our Chemotherapy Toxicity Table. Myelosuppression is a common adverse […]
Read More
We received a big update on 2021 Pharmacist Provider Status this month and it is exciting to see that we still on the radar of the federal government. I have just emailed my representative this morning and am asking you to do the same. Pharmacist provider status will not happen without action. I will be placing […]
Read More